{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:59:35Z","timestamp":1791280775670,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"DOI":"10.1309\/ajcpf7nflw8uajep","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T18:25:26Z","timestamp":1319653526000},"page":"712-720","source":"Crossref","is-referenced-by-count":36,"title":["Detection of Genomic Abnormalities in Multiple Myeloma"],"prefix":"10.1093","volume":"136","author":[{"given":"Luise","family":"Hartmann","sequence":"first","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Sanford","family":"Biggerstaff","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal R.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keely M.","family":"Ghirardelli","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne K.","family":"Fritschle","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores L.","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Bennington","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica E.","family":"de Baca","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Loken","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Zehentner","sequence":"additional","affiliation":[{"name":"Department of Molecular Analysis, HematoLogics, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"key\n\t\t\t\t20180602024955_b1-1360712","first-page":"200","article-title":"Plasma cell neoplasms","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"McKenna","year":"2008","edition":"4th ed"},{"key":"key\n\t\t\t\t20180602024955_b2-1360712","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.21390","article-title":"Combinations of cytogenetics and International Scoring System can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation","volume":"84","author":"Inamoto","year":"2009","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20180602024955_b3-1360712","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma","volume":"23","author":"Kyle","year":"2009","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602024955_b4-1360712","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.V98.7.2229","article-title":"Hypodiploidy is a major prognostic factor in multiple myeloma","volume":"98","author":"Smadja","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602024955_b5-1360712","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization","volume":"95","author":"Zojer","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602024955_b6-1360712","first-page":"3366","article-title":"Prognostic value of cytogenetics in multiple myeloma","volume":"91","author":"Seong","year":"1998","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602024955_b7-1360712","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3324\/haematol.2009.016436","article-title":"Combining chromosomal aberrations t(4;14) and del(17p13) with ISS allows a stratification of myeloma patients undergoing autologous stem cell transplantation","volume":"95","author":"Neben","year":"2010","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180602024955_b8-1360712","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","volume":"23","author":"Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602024955_b9-1360712","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/cncr.25775","article-title":"Chromosomal aberrations +1q21 and del(17)(p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone","volume":"117","author":"Klein","year":"2011","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180602024955_b10-1360712","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180602024955_b11-1360712","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2010.030296","article-title":"Proliferation is a central independent prognostic factor and target for personalized and risk adapted treatment in multiple myeloma","volume":"96","author":"Hose","year":"2011","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180602024955_b12-1360712","first-page":"47","volume-title":"Blood: Textbook of Hematology","author":"Jandl","year":"1996"},{"key":"key\n\t\t\t\t20180602024955_b13-1360712","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2353\/jmoldx.2009.080101","article-title":"Statistical treatment of fluorescence in situ hybridization validation data to generate normal reference ranges using Excel functions","volume":"11","author":"Ciolino","year":"2009","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t20180602024955_b14-1360712","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cyto.b.20512","article-title":"Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell\u2013related disorders","volume":"78","author":"Paiva","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"key\n\t\t\t\t20180602024955_b15-1360712","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cancergencyto.2008.11.007","article-title":"Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment","volume":"189","author":"Pozdnyakova","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"key\n\t\t\t\t20180602024955_b16-1360712","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002770000245","article-title":"Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement","volume":"80","author":"Draube","year":"2001","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t20180602024955_b17-1360712","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12185-010-0651-4","article-title":"Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting","volume":"92","author":"Cumova","year":"2010","journal-title":"Int J Hematol"},{"key":"key\n\t\t\t\t20180602024955_b18-1360712","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1055-9965.EPI-07-2649","article-title":"Effect of tissue shipping on plasma cell isolation, viability, and RNA integrity in the context of a centralized good laboratory practice\u2013certified tissue banking facility","volume":"17","author":"Ahmann","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20180602024955_b19-1360712","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.1998.00623.x","article-title":"The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells","volume":"100","author":"Jourdan","year":"1998","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602024955_b20-1360712","first-page":"116","article-title":"Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization","volume":"29","author":"Chen","year":"2007","journal-title":"Exp Oncol"},{"key":"key\n\t\t\t\t20180602024955_b21-1360712","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1525-1578(10)60588-0","article-title":"A practical approach to the detection of prognostically significant genomic aberrations in multiple myeloma","volume":"7","author":"Chen","year":"2005","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t20180602024955_b22-1360712","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","article-title":"High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH","volume":"96","author":"Shaugnessy","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602024955_b23-1360712","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2006.11.015","article-title":"Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the region of Southern Denmark","volume":"174","author":"Christensen","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"key\n\t\t\t\t20180602024955_b24-1360712","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/gcc.20809","article-title":"Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasia","volume":"49","author":"Put","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t20180602024955_b25-1360712","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1182\/blood-2010-04-279596","article-title":"A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value","volume":"116","author":"Walker","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602024955_b26-1360712","first-page":"1365","article-title":"Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry","volume":"90","author":"Sarasquete","year":"2005","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180602024955_b27-1360712","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1373\/clinchem.2005.061259","article-title":"Minimal disease detection and confirmation in hematologic malignancies: combining cell sorting with clonality profiling","volume":"52","author":"Zehentner","year":"2006","journal-title":"Clin Chem"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/136\/5\/712\/24991444\/ajcpath136-0712.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T04:31:43Z","timestamp":1713069103000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/136\/5\/712\/1766001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,11,1]]},"published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpf7nflw8uajep","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,11,1]]},"published":{"date-parts":[[2011,11,1]]}}}